Survival of patients in the Leicester series compared with the CALGB series when classified by prognostic group
| Group | No. of patients | Median survival (months) | One year survival (%) | Two year survival (%) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Leicester | CALGB | Leicester | CALGB | Leicester | CALGB | Leicester | CALGB | ||||
| 1 | 22 | 36 | 14.8 | 13.9 | 55.9 | 63 | 16.8 | 38 | |||
| 95% CI | 8.5 to 21.2 | 11.1 to 31.4 | 33 to 78.8 | 46 to 77 | 0 to 36.5 | 23 to 55 | |||||
| 2 | 2 | 36 | 6.4 | 9.5 | 0 | 41 | 0 | 21 | |||
| 95% CI | 6.9 to 14.7 | 26 to 57 | 10 to 37 | ||||||||
| 3 | 55 | 146 | 6.6 | 9.2 | 29.0 | 30 | 5.3 | 10 | |||
| 95% CI | 3.0 to 10.1 | 7.5 to 10.5 | 16.1 to 41.9 | 23 to 37 | 0 to 14.6 | 6 to 16 | |||||
| 4 | 5 | 33 | 8.1 | 6.5 | 40 | 25 | 0 | 6 | |||
| 95% CI | 3.7 to 12.5 | 3.7 to 9.4 | 0 to 82.9 | 14 to 42 | 2 to 17 | ||||||
| 5 | 30 | 73 | 3.4 | 4.4 | 3.5 | 7 | 0 | 0 | |||
| 95% CI | 2.5 to 4.2 | 3.4 to 5.1 | 0 to 10.2 | 3 to 15 | |||||||
| 6 | 9 | 13 | 1.1 | 1.4 | 0 | 0 | 0 | 0 | |||
| 95% CI | 0.4 to 1.8 | 0.5 to 3.6 | |||||||||
| Total | 133 | 337 | |||||||||